COSCIENS Biopharma Inc. Quarterly General And Administrative Expense in USD from Q2 2018 to Q1 2024

Taxonomy & unit: ifrs-full: USD
Summary: COSCIENS Biopharma Inc. quarterly/annual General And Administrative Expense history and growth rate from Q2 2018 to Q1 2024.
COSCIENS Biopharma Inc. General And Administrative Expense for the quarter ending March 31, 2024 was $3.51M, a 52.4% increase year-over-year.
COSCIENS Biopharma Inc. General And Administrative Expense for the twelve months ending March 31, 2024 was $9.93M, a 14.5% increase year-over-year.
COSCIENS Biopharma Inc. annual General And Administrative Expense for 2023 was $8.72M, a 6% increase from 2022.
COSCIENS Biopharma Inc. annual General And Administrative Expense for 2022 was $8.23M, a 13.3% increase from 2021.
COSCIENS Biopharma Inc. annual General And Administrative Expense for 2021 was $7.27M, a 23.3% increase from 2020.

General And Administrative Expense, Trailing 12 Months (USD)

General And Administrative Expense, Quarterly (USD)

General And Administrative Expense, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q1 2024	$9.93M	$3.51M	+$1.21M	+52.4%	Jan 1, 2024	Mar 31, 2024	6-K	2024-05-16
Q4 2023	$8.72M	$2.59M	+$582K	+28.9%	Oct 1, 2023	Dec 31, 2023	20-F/A	2024-07-17
Q3 2023	$8.14M	$1.79M	-$483K	-21.2%	Jul 1, 2023	Sep 30, 2023	6-K	2023-11-09
Q2 2023	$8.63M	$2.03M	-$50K	-2.4%	Apr 1, 2023	Jun 30, 2023	6-K	2023-08-09
Q1 2023	$8.68M	$2.31M	+$445K	+23.9%	Jan 1, 2023	Mar 31, 2023	6-K	2024-05-16
Q4 2022	$8.23M	$2.01M	-$1.12M	-35.7%	Oct 1, 2022	Dec 31, 2022	20-F/A	2024-07-17
Q3 2022	$9.35M	$2.27M	+$1.05M	+85.2%	Jul 1, 2022	Sep 30, 2022	6-K	2023-11-09
Q2 2022	$8.3M	$2.08M	+$438K	+26.6%	Apr 1, 2022	Jun 30, 2022	6-K	2023-08-09
Q1 2022	$7.86M	$1.86M	+$597K	+47.2%	Jan 1, 2022	Mar 31, 2022	6-K	2023-05-09
Q4 2021	$7.27M	$3.13M	+$682K	+27.9%	Oct 1, 2021	Dec 31, 2021	20-F/A	2024-07-17
Q3 2021	$6.59M	$1.23M	+$48K	+4.07%	Jul 1, 2021	Sep 30, 2021	6-K	2022-11-03
Q2 2021	$6.54M	$1.65M	+$504K	+44.2%	Apr 1, 2021	Jun 30, 2021	6-K/A	2022-08-04
Q1 2021	$6.03M	$1.26M	+$140K	+12.5%	Jan 1, 2021	Mar 31, 2021	6-K	2022-05-11
Q4 2020	$5.89M	$2.45M	+$757K	+44.8%	Oct 1, 2020	Dec 31, 2020	20-F/A	2024-02-15
Q3 2020	$5.14M	$1.18M	-$184K	-13.5%	Jul 1, 2020	Sep 30, 2020	6-K	2021-11-04
Q2 2020	$5.32M	$1.14M	-$782K	-40.7%	Apr 1, 2020	Jun 30, 2020	6-K	2021-08-05
Q1 2020	$6.1M	$1.12M	-$513K	-31.3%	Jan 1, 2020	Mar 31, 2020	6-K	2021-05-05
Q4 2019	$6.62M	$1.69M			Oct 1, 2019	Dec 31, 2019	20-F	2022-03-29
Q3 2019		$1.36M	-$1.08M	-44.1%	Jul 1, 2019	Sep 30, 2019	6-K	2020-11-05
Q2 2019		$1.92M	-$81K	-4.04%	Apr 1, 2019	Jun 30, 2019	6-K	2020-08-06
Q1 2019		$1.64M			Jan 1, 2019	Mar 31, 2019	6-K/A	2020-05-11
Q3 2018		$2.44M			Jul 1, 2018	Sep 30, 2018	6-K	2019-11-07
Q2 2018		$2M			Apr 1, 2018	Jun 30, 2018	6-K	2019-08-13

* An asterisk sign (*) next to the value indicates that the value is likely invalid.